EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing personalized medicine for tuberculosis through the application of immune profiling

Vo Thuy Anh Thu, Ly Da Dat, Rannissa Puspita Jayanti, Hoang Kim Tu Trinh, Tran Minh Hung, Yong-Soon Cho, Nguyen Phuoc Long, Jae-Gook Shin

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1108155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Vo Thuy Anh Thu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Tuberculosis, Mycobacterium tuberculosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While early and precise diagnosis is the key to eliminating tuberculosis (TB), conventional methods using culture conversion or sputum smear microscopy have failed to meet demand. This is especially true in high-epidemic developing countries and during pandemic-associated social restrictions. Suboptimal biomarkers have restricted the improvement of TB management and eradication strategies. Therefore, the research and development of new affordable and accessible methods are required. Following the emergence of many high-throughput quantification TB studies, immunomics has the advantages of directly targeting responsive immune molecules and significantly simplifying workloads. In particular, immune profiling has been demonstrated to be a versatile tool that potentially unlocks many options for application in TB management. Herein, we review the current approaches for TB control with regard to the potentials and limitations of immunomics. Multiple directions are also proposed to hopefully unleash immunomics’ potential in TB research, not least in revealing representative immune biomarkers to correctly diagnose TB. The immune profiles of patients can be valuable covariates for model-informed precision dosing-based treatment monitoring, prediction of outcome, and the optimal dose prediction of anti-TB drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisMycobacterium tuberculosisHumansPrecision MedicineAntitubercular AgentsBiomarkersSputum

Stichwörter der Autor:innen

biomarkersimmunomicsmodel-informed precision dosingmulti-omicspersonalized medicinetuberculosis

Substanzen

Antitubercular AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
  • Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.
  • Center for Molecular Biomedicine, University of Medicine and Pharmacy at Ho Chi Minh, Ho Chi Minh City, Vietnam.
  • Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Thu, V. T. A., Dat, L. D., Jayanti, R. P., Trinh, H. K. T., Hung, T. M., Cho, Y. S., Long, N. P., & Shin, J. G. (2023). Advancing personalized medicine for tuberculosis through the application of immune profiling. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1108155

Vancouver

Thu VTA, Dat LD, Jayanti RP, Trinh HKT, Hung TM, Cho YS, et al. Advancing personalized medicine for tuberculosis through the application of immune profiling. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1108155

BibTeX
@article{Thu2023,
  author = {Thu, Vo Thuy Anh and Dat, Ly Da and Jayanti, Rannissa Puspita and Trinh, Hoang Kim Tu and Hung, Tran Minh and Cho, Yong-Soon and Long, Nguyen Phuoc and Shin, Jae-Gook},
  title = {Advancing personalized medicine for tuberculosis through the application of immune profiling},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1108155}
}
Kostenlos starten →